Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Vendor Qualification and Re-Evaluation – V 2.0

Posted on By

API Manufacturing: SOP for Vendor Qualification and Re-Evaluation – V 2.0

Standard Operating Procedure for Vendor Qualification and Re-Evaluation in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/180/2025
Supersedes SOP/API/180/2022
Page No. Page 1 of 15
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To establish a standard procedure for the qualification and re-evaluation of vendors supplying raw materials, excipients, solvents, packaging components, and other critical inputs used in API manufacturing, ensuring compliance with GMP and regulatory requirements.

2. Scope

This SOP applies to all vendors supplying materials used in the manufacturing of Active Pharmaceutical Ingredients (APIs) including starting materials, reagents, intermediates, solvents, and

primary/secondary packaging materials.

3. Responsibilities

  • Purchase Department: Identifies potential vendors and coordinates initial documentation.
  • QA Department: Conducts technical review, audits, qualification, and maintains vendor approval status.
  • QC Department: Evaluates incoming material quality and provides analytical feedback.
  • Warehouse: Ensures material segregation and usage based on vendor status.
See also  API Manufacturing: SOP for Temperature Mapping in Drying Chambers - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for vendor approval decisions and ensuring vendors continuously meet GMP standards and product quality requirements.

5. Procedure

5.1 Vendor Categorization

  1. Vendors shall be categorized based on the type of material supplied:
    • Category A: API starting materials, solvents, reagents
    • Category B: Packaging materials (labels, containers)
    • Category C: Other service providers (e.g., testing labs, logistics)

5.2 Vendor Qualification Process

  1. Qualification steps:
    • Request vendor for Vendor Questionnaire (Annexure-1)
    • Obtain technical dossier including:
      • GMP certificate
      • Manufacturing license
      • ISO/DMF/CEP certifications (if applicable)
      • Material specifications and CoA formats
    • Perform site audit for Category A vendors using Vendor Audit Checklist (Annexure-2)
    • Evaluate documentation and assign qualification status:
      • Approved
      • Conditionally Approved
      • Not Approved
  2. Document all findings in the Vendor Qualification Report (Annexure-3).

5.3 Evaluation Criteria

  1. Qualification decision is based on:
    • Material quality performance (initial 3 lots)
    • Compliance to specifications and regulatory documentation
    • Audit observations (if applicable)
    • History of complaints or deviations

5.4 Vendor Re-Evaluation

  1. Re-evaluation to be conducted:
    • Annually for critical material suppliers
    • Biennially for packaging and non-critical vendors
    • Immediately in case of quality failures or regulatory alerts
  2. Parameters for re-evaluation:
    • Lot rejection rates
    • Complaint history
    • Changes in ownership or manufacturing process
    • Updated regulatory documentation
  3. Record re-evaluation details in Vendor Re-Evaluation Form (Annexure-4)
See also  API Manufacturing: SOP for Risk-Based Inspection Planning - V 2.0

5.5 Vendor Status Management

  1. Maintain Approved Vendor List (Annexure-5) with:
    • Vendor Name
    • Material Supplied
    • Approval Date
    • Status (Approved, Conditional, Blacklisted)
  2. Ensure that ERP/SAP system reflects current vendor status to prevent unapproved material usage.

5.6 Disqualification of Vendors

  1. Vendor may be disqualified due to:
    • Repeated quality failures
    • Audit non-compliance
    • Regulatory warning letters
    • Non-fulfillment of contractual obligations
  2. Disqualification must be documented and justified in Vendor Disqualification Form (Annexure-6).

6. Abbreviations

  • QA: Quality Assurance
  • QC: Quality Control
  • GMP: Good Manufacturing Practice
  • DMF: Drug Master File
  • ERP: Enterprise Resource Planning

7. Documents

  1. Vendor Questionnaire (Annexure-1)
  2. Vendor Audit Checklist (Annexure-2)
  3. Vendor Qualification Report (Annexure-3)
  4. Vendor Re-Evaluation Form (Annexure-4)
  5. Approved Vendor List (Annexure-5)
  6. Vendor Disqualification Form (Annexure-6)

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • 21 CFR Part 211 – Subpart E: Control of Components and Drug Product Containers and Closures
  • EU GMP Guidelines – Chapter 5
See also  API Manufacturing: SOP for Recrystallization for API Purification - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Vendor Questionnaire

Vendor Name Address GMP Certified ISO Certified Regulatory Filings
ABC Chemicals Mumbai Yes ISO 9001 DMF Filed (US/EU)

Annexure-2: Vendor Audit Checklist

Section Audit Criteria Compliance Remarks
Manufacturing Area Cleanliness, Layout Yes Acceptable
Documentation Batch records, SOPs Yes Complete

Annexure-3: Vendor Qualification Report

Vendor Material Audit Result Decision Date
ABC Chemicals Toluene Compliant Approved 01/04/2025

Annexure-4: Vendor Re-Evaluation Form

Vendor Material Last Evaluation Observations Re-Approval
XYZ Corp IPA 02/03/2024 Minor Deviation Yes

Annexure-5: Approved Vendor List

Vendor Material Status Approval Date
ABC Chemicals Solvents Approved 01/04/2025

Annexure-6: Vendor Disqualification Form

Vendor Reason Disqualification Date Approved By
DEF Labs Repeated CoA failures 10/04/2025 QA Head

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
14/04/2025 2.0 Included audit and re-evaluation templates Compliance update QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Prefilled Syringe Filling Machine Operation – V 2.0
Next Post: Analytical Method Development: Total Viable Count Method Optimization – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version